AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aumeran, C.
Right arrow Articles by Bonnet, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aumeran, C.
Right arrow Articles by Bonnet, R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2003, p. 2958-2961, Vol. 47, No. 9
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.9.2958-2961.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Effects of Ser130Gly and Asp240Lys Substitutions in Extended-Spectrum ß-Lactamase CTX-M-9

C. Aumeran,1 C. Chanal,1 R. Labia,2 D. Sirot,1 J. Sirot,1 and R. Bonnet1*

Laboratoire de Bactériologie, Faculté de Médecine, 63001 Clermont-Ferrand, Cedex,1 UMR 175, CNRS-MNHN, 29000 Quimper, France2

Received 17 April 2003/ Returned for modification 23 May 2003/ Accepted 4 June 2003

In CTX-M-9 extended-spectrum ß-lactamases (ESBLs), an S130G mutation induced a 40- to 650-fold increase in 50% inhibitory concentrations but decreased hydrolytic activity against cefotaxime. A D240K mutation did not modify enzymatic efficiency against ceftazidime. Residue K240 could interact with Q270 and therefore not with ceftazidime, in contrast with what was observed with certain TEM/SHV-type ESBLs.


* Corresponding author. Mailing address: Faculté de Médecine, Service de Bactériologie-Virologie, 28, Place Henri Dunant, 63 001 Clermont-Ferrand Cedex, France. Phone: 33 (0)4 73 17 81 50. Fax: 33 (0)4 73 27 74 94. E-mail: richard.bonnet{at}u-clermont1.fr.


Antimicrobial Agents and Chemotherapy, September 2003, p. 2958-2961, Vol. 47, No. 9
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.9.2958-2961.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.